Heron Therapeutics Inc (HRTX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Barry D. Quart |
| Employees: | 300 |
| Web site: | herontx.com |
|
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
8582514400
| |
-
Formally known as:
- Advanced Polymer Systems Inc
- AP Pharma Inc
- AP PHARMA INC
- AP Pharma Inc
- HERON THERAPEUTICS INC NEW COM STK
| Date | Ratio |
|---|---|
| 2007-05-25 | 1:4 |
| 2014-01-13 | 1:20 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Heron Therapeutics, Inc. engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy.
Please log in first to see chart